Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biogen/Capsigen Ink Up To $1.3bn Deal For Improved AAV Capsids
Collaboration Is Latest Focused On Next-Generation Gene Therapies
May 12 2021
•
By
Alaric DeArment
Biogen and Capsigen ink a $1.3bn deal for improved AAV capsids • Source: Shutterstock
More from Gene Therapies
More from Advanced Therapies